Azvudine reduces the mortality rate of patients with Coronavirus disease 2019: a single-center retrospective analysis study
Z Zhong, X Liu, X Zhou, J Zhong, L Zhou, R Li, X Liu - 2024 - researchsquare.com
Background: Several therapeutic drugs have been authorized for the treatment of patients
with Coronavirus disease 2019 (COVID-19). However, further research on the mechanisms …
with Coronavirus disease 2019 (COVID-19). However, further research on the mechanisms …
· A Retrospective Cohort Study of the Efficacy and Safety of Oral Azvudine Versus Paxlovid in Elderly Hospitalized COVID-19 Patients Aged Over 60 Years
B Yu, H Wang, G Li, J Sun, H Luo, M Yang, M Cheng… - papers.ssrn.com
Background: COVID-19 has caused a great test to people's life safety, especially for the
elderly group over 60 years old. Azvudine and Paxlovid were widely used as anti-COVID-19 …
elderly group over 60 years old. Azvudine and Paxlovid were widely used as anti-COVID-19 …